Last reviewed · How we verify
Non-Radiographic Axial Spondyloarthritis
Approved treatments
- Cosentyx · Janssen Research & Development, LLC
- tumor necrosis factor inhibitors (TNFi) · Pfizer
- Kyntheum · Valeant Luxembourg
Kyntheum works by blocking the interleukin-17 receptor, a protein that plays a key role in inflammation. - TNF Inhibitor · Pfizer
- Cosentyx · Novartis
Secukinumab selectively binds IL-17A cytokine and inhibits its interaction with IL-17 receptor. - Taltz · Yale University
- Taltz · Eli Lilly
Humanized IgG4 monoclonal antibody that selectively binds IL-17A cytokine and inhibits its interaction with IL-17 receptor.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Non-Radiographic Axial Spondyloarthritis patent landscape — cliff calendar, originator estates, attackable patents
- Non-Radiographic Axial Spondyloarthritis treatment landscape brief
- Non-Radiographic Axial Spondyloarthritis treatment updates RSS
Frequently asked questions about Non-Radiographic Axial Spondyloarthritis
What drugs treat Non-Radiographic Axial Spondyloarthritis?
Tracked treatments include Cosentyx, tumor necrosis factor inhibitors (TNFi), Kyntheum, TNF Inhibitor, Taltz.
What is the treatment for Non-Radiographic Axial Spondyloarthritis?
Standard treatment for Non-Radiographic Axial Spondyloarthritis includes Cosentyx, tumor necrosis factor inhibitors (TNFi), Kyntheum, TNF Inhibitor, Taltz. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Non-Radiographic Axial Spondyloarthritis patent cliff · Non-Radiographic Axial Spondyloarthritis CI report
- Treatment: Cosentyx · Janssen Research & Development, LLC
- Treatment: tumor necrosis factor inhibitors (TNFi) · Pfizer
- Treatment: Kyntheum · Valeant Luxembourg
- Treatment: TNF Inhibitor · Pfizer
- Treatment: Cosentyx · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing